In colorectal cancer, NLR could be confirmed as prognostic biomarker for OS (Naszai et al. 2021) and in gastric cancer poor survival was associated with CRP, NLR and GPS/mGPS (Kim et al. 2020) in other systematic reviews and meta-analyses. This evidence concerns the gene CRP and colorectal cancer.